Literature DB >> 19524940

Dual expression lentiviral vectors for concurrent RNA interference and rescue.

Narendra V Sankpal1, Timothy P Fleming, William E Gillanders.   

Abstract

RNA interference (RNAi) is a powerful new tool for the selective ablation of gene expression, facilitating loss-of-function studies. However, appropriate controls are considered essential to confirm the specificity of RNAi experiments. The most stringent control is rescue of the target gene in a form that is refractory to RNAi. To facilitate rescue of the target gene, we have created improved dual expression lentiviral vectors with the ability to simultaneously drive expression of a shRNA for RNA interference and a rescue transgene in a single vector system. In proof-of-principle experiments, we ablated more than 90% of target gene expression by targeting either the open reading frame, or the 3' UTR region. Target gene expression was successfully rescued with a cDNA containing silent third-codon point mutations in the targeted region or with native cDNA when the 3' UTR was targeted. Finally, expression of the rescue transgene can be manipulated by positional cloning and appropriate promoter selection. The dual expression lentiviral vectors described here represent a versatile strategy for confirming the integrity of RNAi experiments and may facilitate functional analyses even in the absence of an established gain-of-function model system.

Entities:  

Mesh:

Year:  2009        PMID: 19524940      PMCID: PMC3907264          DOI: 10.1016/j.jss.2009.02.004

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  17 in total

1.  IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector.

Authors:  H Mizuguchi; Z Xu; A Ishii-Watabe; E Uchida; T Hayakawa
Journal:  Mol Ther       Date:  2000-04       Impact factor: 11.454

2.  Whither RNAi?

Authors: 
Journal:  Nat Cell Biol       Date:  2003-06       Impact factor: 28.824

3.  Rescue of the TTF2 knockdown phenotype with an siRNA-resistant replacement vector.

Authors:  Yan Jiang; David H Price
Journal:  Cell Cycle       Date:  2004-09-10       Impact factor: 4.534

4.  Induction of an interferon response by RNAi vectors in mammalian cells.

Authors:  Alan J Bridge; Stephanie Pebernard; Annick Ducraux; Anne-Laure Nicoulaz; Richard Iggo
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

6.  RNA interference rescue by bacterial artificial chromosome transgenesis in mammalian tissue culture cells.

Authors:  Ralf Kittler; Laurence Pelletier; Chunling Ma; Ina Poser; Steffi Fischer; Anthony A Hyman; Frank Buchholz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-03       Impact factor: 11.205

7.  Cre-lox-regulated conditional RNA interference from transgenes.

Authors:  Andrea Ventura; Alexander Meissner; Christopher P Dillon; Michael McManus; Phillip A Sharp; Luk Van Parijs; Rudolf Jaenisch; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

8.  EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.

Authors:  Walid A Osta; Yian Chen; Kaidi Mikhitarian; Michael Mitas; Mohamed Salem; Yusuf A Hannun; David J Cole; William E Gillanders
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

9.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

10.  Improved silencing vector co-expressing GFP and small hairpin RNA.

Authors:  Shin-ichiro Kojima; Danijela Vignjevic; Gary G Borisy
Journal:  Biotechniques       Date:  2004-01       Impact factor: 1.993

View more
  4 in total

1.  EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancer.

Authors:  Narendra V Sankpal; Timothy P Fleming; William E Gillanders
Journal:  Mol Cancer Res       Date:  2013-02-01       Impact factor: 5.852

2.  Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion.

Authors:  Narendra V Sankpal; John D Mayfield; Mike W Willman; Timothy P Fleming; William E Gillanders
Journal:  Breast Cancer Res       Date:  2011-12-01       Impact factor: 6.466

3.  A novel method to investigate the effects of gene mutations at the cellular level using a dual expression lentiviral vector.

Authors:  Liyun Huang; Feixia Peng; Yun Wei; Wei He; Shasha Zhao; Juan Wang; Yang Zhang; Houliang Zhao; Wensheng Deng
Journal:  Biosci Rep       Date:  2019-05-02       Impact factor: 3.840

4.  EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer.

Authors:  S D Soysal; S Muenst; T Barbie; T Fleming; F Gao; G Spizzo; D Oertli; C T Viehl; E C Obermann; W E Gillanders
Journal:  Br J Cancer       Date:  2013-03-21       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.